Articles tagged with: Truvada

Ontario to cover HIV prevention pill under public health plan

published: September, 22, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Activism, As Prevention , Current Affairs, General Health, Treatment Guidelines -including when to start, Health, Revolving Door, Treatment, Guest Authors, Media

Once-daily pill contains two anti-HIV drugs that reduce the risk of sexual transmission of virus

Ontario to cover HIV prevention pill under public health plan

Generic versions of pre-exposure prophylaxis or PrEP to prevent HIV are becoming more available in Canada. (CBC) To read the complete article, visit CBC News, here. Ontario will soon cover a combination HIV prevention pill that is now available in generic form, HIV advocates say. The once-daily pill contains two anti-HIV drugs that reduce the risk of sexual transmission in HIV-negative individuals. Pre-exposure prophylaxis, or PrEP, originally cost about $1,000 a month as the brand nam

I made an HIV prevention video for guys who hate condoms. Here’s why (NSFW)

published: July, 18, 2017 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Alternative Therapies, Social Media, As Prevention , Gay Men, Youth, General Health, Treatment Guidelines -including when to start, Health, Revolving Door, Treatment, Guest Authors, Media

“I thought that we needed something bolder, something sexier, and something that reflected the realities of gay sex...”

I made an HIV prevention video for guys who hate condoms. Here’s why (NSFW)

Mr. Leather LA 2014 and LA County HIV Commission member Eric Paul Leue    Photo: John Kiffmeyer To read the complete article by Chris Tipton-King visit Huffington Post, here. If you weren’t aware that Gilead recently started running Truvada for PrEP ads, I wouldn’t blame you: they’re exactly the sort of vanilla, stock-photo-and-fine-print yawners that you might expect from a pharmaceutical company. For a prevention strategy meant for men who enjoy dicks in butts au-natural, most

Surprise FDA approval of generic Truvada is a 'wakeup call' for activists

published: July, 10, 2017 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, Activism, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, Women, Revolving Door, International , Treatment, Guest Authors, Media

Advocates and doctors are scrambling to understand exactly when the generic will become available and how much it will cost. From TheBody.com, Sony Salzman reports.

Surprise FDA approval of generic Truvada is a 'wakeup call' for activists

To read the complete article by Sony Salzman, vsit TheBody.com, here. The surprise approval of generic Truvada (tenofovir disoproxil fumarate and emtricitabine) by the U.S. Food and Drug Administration (FDA) on June 9 left patients, advocates and doctors scrambling to understand exactly when the generic will become available and how much it will cost. After weeks of speculation, both of those questions remain unanswered -- locked behind a confidential settlement agreement between TEVA,

FDA approves a generic form of PrEP

published: June, 16, 2017 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, As Prevention , Gay Men, Youth, Current Affairs, Treatment Guidelines -including when to start, Women, Revolving Door, International , Treatment, Guest Authors, Media

Sexual health advocates hope this will make widen access to PrEP, the medication that helps prevent people contracting HIV

FDA approves a generic form of PrEP

To read the complete article by David Hudson visit Gay Star News, here. The Food and Drug Administration (FDA) in the US has approved the first generic form of PrEP. PrEP is medication that can be taken by someone to prevent them becoming infected with HIV. It’s a daily pill of Truvada, produced by Gilead Sciences. Truvada is a combination of Emtricitabine and Tenofovir Disoproxil Fumarate The use of PrEP has been credited with driving down HIV infection rates in countries where it has

Are women prepared for HIV PrEP?

published: May, 05, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Dating, African, Caribbean and Black, As Prevention , General Health, Treatment Guidelines -including when to start, Women, Research, Revolving Door, International , Treatment, Lifestyle, Guest Authors

From KALW.org, Chloe Lessard: "some women and trans folks are wondering why a drug that could potentially save their lives hasn’t been aggressively promoted in their communities."

Are women prepared for HIV PrEP?

To read the complete article by Chloe Lessard, visit KALW.org, here. Did you know that you can take a drug to reduce your risk of getting HIV? If you’re a gay man, you’ve probably heard of it. It’s a daily regimen called PrEP, or pre-exposure prophylaxis. Maybe you’ve even seen ads for it on BART trains or clinic brochures, usually targeting men who sleep with other men. But PrEP doesn’t only benefit men, and some women and trans folks are wondering why a drug that could potential

What’s Reckless About a Campaign to Prevent HIV?

published: April, 20, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Gay Men, General Health, Treatment Guidelines -including when to start, Health, Revolving Door, International , Treatment, Guest Authors, Media

From The Advocate: educating people about the availability of PrEP shouldn't be controversial, writes Dr. Michael Gottlieb.

What’s Reckless About a Campaign to Prevent HIV?

The complete article by Dr. Michael Gottlieb can be read at The Advocate, here. As a physician who has been treating people with HIV since the beginning of the epidemic and as a witness to more than a few AIDS-related controversies, I’m profoundly puzzled by how some are overreacting to a new HIV prevention campaign. F*ck w/out Fear is the admittedly audacious tagline of the Los Angeles LGBT Center’s new campaign to raise awareness about pre-exposure prophylaxis, which consists of tak

Accuracy Watchdog Eyes Media for Mistakes in HIV Transmission Risk

published: February, 03, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Activism, As Prevention , General Health, Current Affairs, Treatment Guidelines -including when to start, Mental Health, Health, Revolving Door, International , Treatment, Guest Authors

On getting U=U and PrEP facts right .POZ reports on this joint initiative of Human Rights Campaign and Prevention Access Campaign.

Accuracy Watchdog Eyes Media for Mistakes in HIV Transmission Risk

This article previously appeared at POZ, here. A new initiative called Accuracy Watchdog aims to correct erroneous reporting about HIV transmission risks. A partnership between LGBT advocacy group Human Rights Campaign (HRC) and Prevention Access Campaign (PAC), Accuracy Watchdog launched this month. The joint initiative will, for example, correct scientific misinformation pertaining to people living with HIV who are on treatment and maintain an undetectable viral load—a concept known as

Implants and injectables: PrEP in the future

published: January, 25, 2017 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, As Prevention , Gay Men, Treatment Guidelines -including when to start, Women, Research, International , Revolving Door, Treatment, Guest Authors

Is the future all about implants, or will it offer multiple options for people who want to use PrEP? For AIDSmap.com, Keith Alcorn reports on several developments in PrEP delivery.

Implants and injectables: PrEP in the future

Last month’s announcement that the Bill and Melinda Gates Foundation will give up to $140 million to a Boston drug device manufacturer to develop an implantable mini-pump to deliver drugs for pre-exposure prophylaxis (PrEP) against HIV infection has focused attention on the future of PrEP. Is the future all about implants, or will it offer multiple options for people who want to use PrEP? Implants and other long-acting drug delivery systems have attracted interest as a means of delivering P

Lifegiving gifts

published: December, 20, 2016 Written by // Alex Sparrowhawk Categories // Activism, Social Media, Community Events, As Prevention , Gay Men, General Health, Current Affairs, Treatment Guidelines -including when to start, Mental Health, Health, Sexual Health, International , Treatment, Living with HIV, Opinion Pieces, Alex Sparrowhawk

From the U.K., Alex Sparrowhawk says, "... perhaps the best gift of all would be to share our knowledge and spirit with one another."

Lifegiving gifts

During another successful National HIV Testing Week I’ve spoken to a lot of different people about my own experiences of testing, and the one test that altered my life forever. I’m now seven years into my journey with HIV and with World AIDS Day 2016 approaching I’ve been thinking about the remarkable changes that have happened during that time. Seven years ago I was told I would need to start medication immediately, I was diagnosed ‘late’ and even though it was only five or six mon

NHS England announces major new PrEP trial for 2017

published: December, 16, 2016 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, International , Revolving Door, Treatment, Guest Authors

For AIDSmap.com, Gus Cairns and Roger Pebody report: previous funding increased fivefold, but trial still depends on drug price deal

NHS England announces major new PrEP trial for 2017

NHS England, in collaboration with Public Health England, has announced in a press release today that a major new implementation trial of pre-exposure prophylaxis (PrEP) will start next year. It is planned to enrol at least twice as many as previously anticipated and the funding announced is five times higher than the money for a trial originally announced in March this year. NHS England says that the three-year trial will start in “early financial year 2017/18”, which implies next A

[12 3 4 5  >>